Chuck Akre's SOPH Position Overview
Chuck Akre (via Akre Capital Management LLC) currently holds 3.72 M shares of SOPHiA GENETICS SA (SOPH) worth $18.41 M, representing 0.30% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Chuck Akre has maintained a strategic position in SOPH, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 1.63 M shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Akre's SOPHiA GENETICS (SOPH) Holding Value Over Time
Track share changes against reported price movement
Quarterly SOPHiA GENETICS (SOPH) Trades by Chuck Akre
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +1.48 M | Add 66.22% | 3.72 M | $3.10 |
| Q3 2024 | +317,072 | Add 16.51% | 2.24 M | $3.65 |
| Q2 2024 | +1.63 M | Add 567.51% | 1.92 M | $4.58 |
| Q1 2024 | +287,699 | New Buy | 287,699 | $4.93 |
Chuck Akre's SOPHiA GENETICS Investment FAQs
Chuck Akre first purchased SOPHiA GENETICS SA (SOPH) in Q1 2024, acquiring 287,699 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Akre has held SOPHiA GENETICS SA (SOPH) for 9 quarters since Q1 2024.
Chuck Akre's largest addition to SOPHiA GENETICS SA (SOPH) was in Q2 2024, adding 1,920,432 shares worth $8.8 M.
According to the latest 13F filing for Q1 2026, Chuck Akre's firm, Akre Capital Management LLC, owns 3,719,140 shares of SOPHiA GENETICS SA (SOPH), valued at approximately $18.41 M.
As of the Q1 2026 filing, SOPHiA GENETICS SA (SOPH) represents approximately 0.30% of Chuck Akre's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Akre's peak holding in SOPHiA GENETICS SA (SOPH) was 3,719,140 shares, as reported at the end of Q2 2025.